KNSA · ISSUER CIK 1730430
Kiniksa Pharmaceuticals International, plc
Between Aug 1, 2026 and Oct 29, 2026, 7 Kiniksa Pharmaceuticals International, plc insiders reported $0.00 of open-market purchases and $369K of sales on SEC Form 4.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$369KInsider selling
−$369KNet open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:49 | Sep 1, 2026 | KNSA | CHIEF FINANCIAL OFFICER | M · Exercise | — | +9,104 | 25,258 | +56% | — | ||
| Sep 3, 202616:49 | Sep 1, 2026 | KNSA | CHIEF FINANCIAL OFFICER | F · Tax | $79.28 | −4,404 | 20,854 | -17% | $349K | ||
| Sep 3, 202616:48 | Sep 1, 2026 | KNSA | CHAIRMAN & CEO, Director | M · Exercise | — | +31,318 | 107,492 | +41% | — | ||
| Sep 3, 202616:48 | Sep 1, 2026 | KNSA | CHAIRMAN & CEO, Director | F · Tax | $79.28 | −15,144 | 92,348 | -14% | $1.2M | ||
| Sep 3, 202616:46 | Sep 1, 2026 | KNSA | CHAIRMAN & CEO, Director | M · Exercise | — | +31,318 | 107,492 | +41% | — | ||
| Sep 3, 202616:46 | Sep 1, 2026 | KNSA | CHAIRMAN & CEO, Director | F · Tax | $79.28 | −15,144 | 92,348 | -14% | $1.2M | ||
| Sep 3, 202616:43 | Sep 1, 2026 | KNSA | CHIEF MEDICAL OFFICER | M · Exercise | — | +8,328 | 73,951 | +13% | — | ||
| Sep 3, 202616:43 | Sep 1, 2026 | KNSA | CHIEF MEDICAL OFFICER | F · Tax | $79.28 | −4,029 | 69,922 | -5% | $319K | ||
| Sep 3, 202616:41 | Sep 1, 2026 | KNSA | CHIEF OPERATING OFFICER | M · Exercise | — | +8,285 | 20,314 | +69% | — | ||
| Sep 3, 202616:41 | Sep 1, 2026 | KNSA | CHIEF OPERATING OFFICER | F · Tax | $79.28 | −4,007 | 16,307 | -20% | $318K | ||
| Sep 3, 202616:40 | Sep 3, 2026 | KNSA | CHIEF ACCOUNTING OFFICER | S · Sell10b5-1 | $80.30 | −4,600 | 29,062 | -14% | −$369K | ||
| Sep 3, 202616:40 | Sep 1, 2026 | KNSA | CHIEF ACCOUNTING OFFICER | M · Exercise10b5-1 | — | +11,496 | 39,193 | +42% | — | ||
| Sep 3, 202616:40 | Sep 1, 2026 | KNSA | CHIEF ACCOUNTING OFFICER | F · Tax10b5-1 | $79.28 | −5,531 | 33,662 | -14% | $438K | ||
| Sep 3, 202616:40 | Jul 15, 2026 | KNSA | CHIEF ACCOUNTING OFFICER | A · Grant10b5-1Late 50d | $33.50 | +279 | 27,697 | +1% | $9K | ||
| Aug 21, 202616:35 | Aug 19, 2026 | KNSA | Director | G · Gift | — | −2,600 | 12,745 | -17% | — | ||
| Aug 4, 202616:40 | Aug 1, 2026 | KNSA | Director | M · Exercise | — | +403 | 22,359 | +2% | — |